Janet says, "Despite what the official statistics say, metastatic (stage IV) lung cancer is NOT an automatic death sentence. Newer therapies and personalized medicine now offer such patients months or even years of quality time to spend enjoying family, friends, hobbies, even travel and work. Yet insurance companies and doomsday doctors still tell many patients there's no point in pursuing further treatment. I'm an engineer, a writer, and a stage IV lung cancer patient, and I received a letter from my insurance company [ed: Blue Cross Blue Shield of Illinois] saying there was no need for me to have another biopsy because I was going to die anyway. This blog post is my response to that letter."
I was lucky to have enough slides from a 2011 biopsy to have the University of Colorado test my tumor for the relatively new ROS1 genetic mutation in my tumor tissue. Because I tested positive for ROS1, I was able to enter a clinical trial for the targeted therapy crizotinib, a drug which inhibits my ROS1-driven cancer. The trial treatment eliminated both nodules and has given me No Evidence of Disease Status for five months. I am once again able to enjoy traveling, writing, and doing things with my family. If I had not had leftover biopsy slides, an EMN biopsy would have been my only opportunity to obtain enough tissue to test for ROS1. Without that ROS1 trial and crizotinib, I might be dead by now.
Doctors who don’t keep current on new treatment options and then decide a biopsy “is not going to affect long-term health outcomes” for metastatic lung cancer patients are insuring those patients will die sooner rather than later.
That’s not the kind of health insurance I want. Do you?
Insuring the Terminal Patient
Last year, California was one of several states to introduce right to repair legislation that would force companies to end practices that discourage the independent repair sector, creating a requirement to sell replacement parts, provide documentation, and supply codes to bypass DRM systems that locked new parts out of devices until the company activated them.
The term "meritocracy" was popularized in the UK sociologist Michael Young's 1958 novel, "The Rise of the Meritocracy," in which aristocrats insist that they are the natural rulers of their society based on "objective" measures of worth ("merit" + "aristocracy" = "meritocracy") that are obviously tilted to favor them, a fact that they are conveniently […]
A year ago, smarting over public criticism of its role in promoting division and stoking racism, Facebook announced a major shift in its newsfeed algorithm which would downrank posts from media organizations and uprank the things sent by your friends on the network, in the name of promotion a gentler form of "engagement" that would […]
Seems like drones are doing a lot of jobs these days, from reconnaissance to delivery. Now, we can add “keeping the Death Star safe” to that list. Whether you’re a drone enthusiast or a Star Wars fan, these Star Wars Propel Drones are undeniably the coolest toy around. Yes, that’s a fully functional drone replica […]
It’s spring clearance time for the Boing Boing Store, when some of the best deals from the holidays return even cheaper than before. From top-rated apps to educational software to the cutest record player of all time, they’re all back with a little extra incentive. Shop your heart out before tax season wraps up! Use […]
Big companies want automation on a big scale. Doing that means diving into the tricky world of machine learning and data science. And no matter what platform you’ll be implementing it on, you can learn how with the Machine Learning & Data Science Certification Training Bundle. In 48 hours and through eight courses, this bundle […]